astrazeneca imfinzi - Search News

AstraZeneca faces potential fines in China

Pharmaceutical giant AstraZeneca faces potential fines in China over import taxes

AstraZeneca appointed a new president for its China operations following the arrest of former executive Leon Wang along with other staff members by Chinese authorities

Hosted on MSN · 5h

Drugmaker AstraZeneca flags possible $4.5 million Chinese tax fine

AstraZeneca could face a fine of up to $4.5 million in China over suspected unpaid taxes related to the import of two of its cancer drugs, the pharmaceuticals giant said on Thursday as it continues to gauge the impact of ongoing investigations in the key growth market.

This Is Money on MSN · 4h

AstraZeneca faces potential fines in China over unpaid import taxes

AstraZeneca said the taxes related to two cancer drugs, Imfinzi and Imjudo, and that it was continuing to co-operate with Chinese authorities.

20m

AstraZeneca Q4 Earnings: Revenue And EPS Beat On Higher Cancer And Respiratory Drug Sales, Faces $4.5 Million Potential Fine In China

AstraZeneca Plc (NASDAQ:AZN) reported fourth-quarter sales of $14.89 billion, up 18% year over year (+19% at constant ...

PMLiVE3d

AstraZeneca’s Imfinzi recommended by CHMP to treat small cell lung cancer

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the immunotherapy be approved to treat adults ...

2hon MSN

AstraZeneca Expects Revenue, Earnings Growth Despite Sales Drop in China

Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...

AstraZeneca continues to ‘fully cooperate’ with Chinese authorities

The company said, “In relation to the illegal drug importation allegations, in January 2025, AstraZeneca (AZN) received a Notice of Transfer to ...

AstraZeneca's Imfinzi set for go-ahead by EU to treat lung cancer

AstraZeneca's Imfinzi has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has ...

Cancer drugs help drive fourth-quarter sales beat at AstraZeneca

AstraZeneca PLC on Thursday ended a strong year with better-than-expected fourth quarter earnings and said its pipeline would support further growth in 2025. The Cambridge-based pharmaceuticals firm ...

AstraZeneca’s Imfinzi recommended for approval in EU by CHMP

Imfinzi has been recommended for approval in the European Union, EU, as monotherapy for the treatment of adults with ...

AstraZeneca PLC: Imfinzi recommended for EU approval for LS-SCLC

Imfinzi recommended for approval in the EU by CHMP as first and only immunotherapy for limited-stage small cell lung cancer Recommendation based on ADRIATIC Phase III trial results which ...

AstraZeneca's Imfinzi endorsed for EU approval for lung cancer care

(Alliance News) - AstraZeneca PLC on Monday said Imfinzi has been recommended for approval in the EU as monotherapy for limited-stage small cell lung cancer.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results